Design and in silico analysis of a novel peptide-based multiepitope vaccine against glioblastoma multiforme by targeting tumor-associated macrophage
Reza Salahlou, Safar Farajnia, Effat Alizadeh, Siavoush Dastmalchi, Nasrin Bargahi, Leila Rahbarnia, Safooreh Hoseinpour Steyar · 2024
Read Design and in silico analysis of a novel peptide-based multiepitope vaccine against glioblastoma multiforme by targeting tumor-associated macrophage by Reza Salahlou, Safar Farajnia, Effat Alizadeh, Siavoush Dastmalchi, Nasrin Bargahi, Leila Rahbarnia, Safooreh Hoseinpour Steyar (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11696665.txt.
Description
Reza Salahlou and co-authors describe a 2024 computer-based design for a vaccine aimed at a hard brain tumor. The tumor, called GBM in short, is aided by immune cells that gather inside it. The team targeted a marker on those cells, named CD204, to build a peptide vaccine on screen.
Software picked short protein parts that should rouse killer cells, helper cells, and antibody-making cells. The parts were joined with linkers and a booster part. Checks suggested the design was stable, safe on screen, and able to bind two immune sensors well. Simulated immune replies rose in the models. The authors present it as a hopeful path that still needs lab tests.
Catalog record
| CREATOR | Reza Salahlou, Safar Farajnia, Effat Alizadeh, Siavoush Dastmalchi, Nasrin Bargahi, Leila Rahbarnia, Safooreh Hoseinpour Steyar |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |